TransUnion [TRU] vs CME [CME] Detailed Stock Comparison

TransUnion

NYSE
Loading...

CME Group Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: TransUnion wins in 5 metrics, CME Group Inc. wins in 15 metrics, with 0 ties. CME Group Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric TransUnion CME Group Inc. Better
P/E Ratio (TTM) 44.91 24.34 CME Group Inc.
Price-to-Book Ratio 3.74 3.57 CME Group Inc.
Debt-to-Equity Ratio 115.67 12.86 CME Group Inc.
PEG Ratio 18.42 1.03 CME Group Inc.
EV/EBITDA 14.93 21.55 TransUnion
Profit Margin (TTM) 8.63% 63.31% CME Group Inc.
Operating Margin (TTM) 28.33% 69.66% CME Group Inc.
EBITDA Margin (TTM) 28.33% 69.66% CME Group Inc.
Return on Equity 8.89% 15.92% CME Group Inc.
Return on Assets (TTM) 4.94% 1.55% TransUnion
Free Cash Flow (TTM) $516.70M $4.19B CME Group Inc.
Dividend Yield 0.61% 4.11% CME Group Inc.
1-Year Return -21.26% 0.01% CME Group Inc.
Price-to-Sales Ratio (TTM) 3.85 15.36 TransUnion
Enterprise Value $21.08B $103.28B CME Group Inc.
EV/Revenue Ratio 4.95 15.31 TransUnion
Gross Profit Margin (TTM) 59.33% N/A N/A
Revenue per Share (TTM) $22 $19 TransUnion
Earnings per Share (Diluted) $1.87 $11.73 CME Group Inc.
Beta (Stock Volatility) 1.64 0.30 CME Group Inc.
Short % of Float 3.20% 1.44% CME Group Inc.

TransUnion vs CME Group Inc. Stock Performance Analysis

Loading Price Chart...

TRU
CME

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
TransUnion1.78%-2.18%1.58%-4.81%-19.51%-19.22%
CME Group Inc.-1.28%5.57%-10.97%-15.22%-2.24%-1.33%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
TransUnion-21.26%-12.38%-39.03%104.86%166.12%166.12%
CME Group Inc.0.01%46.40%27.92%186.46%384.94%196.68%

Performance & Financial Health Analysis: TransUnion vs CME Group Inc.

MetricTRUCME
Market Information
Market Cap i$16.38B$103.42B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,816,8102,489,654
90 Day Avg. Volume i1,935,5632,270,221
Last Close$67.31$266.08
52 Week Range$64.51 - $99.39$244.56 - $329.16
% from 52W High-32.28%-19.16%
All-Time High$125.35 (Sep 06, 2021)$329.16 (Mar 03, 2026)
% from All-Time High-46.30%-19.16%
Growth Metrics
Quarterly Revenue Growth0.07%0.15%
Quarterly Earnings Growth1.28%0.21%
Financial Health
Profit Margin (TTM) i0.09%0.63%
Operating Margin (TTM) i0.28%0.70%
Return on Equity (TTM) i0.09%0.16%
Debt to Equity (MRQ) i115.6712.86
Cash & Liquidity
Book Value per Share (MRQ)$22.48$80.03
Cash per Share (MRQ)$3.14$7.56
Operating Cash Flow (TTM) i$831.00M$4.54B
Levered Free Cash Flow (TTM) i$549.89M$4.11B
Dividends
Last 12-Month Dividend Yield i0.61%4.11%
Last 12-Month Dividend i$0.48$12.45

Valuation & Enterprise Metrics Analysis: TransUnion vs CME Group Inc.

MetricTRU (Jun 16, 2025)CME (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i44.9124.34
Forward P/E i18.4222.14
PEG Ratio i18.421.03
Price to Sales (TTM) i3.8515.36
Price to Book (MRQ) i3.743.57
Market Capitalization
Market Capitalization i$16.38B$103.42B
Enterprise Value i$21.08B$103.28B
Enterprise Value Metrics
Enterprise to Revenue i4.9515.31
Enterprise to EBITDA i14.9321.55
Risk & Other Metrics
Beta i1.640.30
Book Value per Share (MRQ) i$22.48$80.03

Financial Statements Comparison: TransUnion vs CME Group Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTRU (2024)CME (2025)
Revenue/Sales i4.18B6.52B
Cost of Goods Sold i1.67B907.00M
COGS % of Revenue i40.0%13.9%
Gross Profit i2.51B5.61B
Gross Margin i60.0%86.1%
Research & Development iN/AN/A
Operating Income (EBIT) i733.40M4.23B
Operating Margin i17.5%64.9%
EBITDA i1.28B98.30M
EBITDA Margin i30.6%1.5%
Pre-Tax Income i401.10M5.33B
Pre-Tax Income % of Revenue i9.6%81.7%
Income Tax i98.80M1.26B
Income Tax % of Revenue i2.4%19.3%
Net Income (Profit) i302.30M4.07B
Profit Margin i7.2%62.5%

Balance Sheet & Liquidity Metrics

MetricTRU (2024)CME (2025)
Cash & Equivalents i679.50M4.42B
Total Current Assets i1.80B165.36B
Total Current Assets % of Revenue i43.1%2,536.0%
Total Current Liabilities i1.06B160.30B
Total Current Liabilities % of Revenue i25.3%2,458.3%
Long-Term Debt i5.12B3.42B
Long-Term Debt % of Revenue i122.3%52.5%
Total Shareholders Equity i4.32B28.73B
Retained Earnings i2.36B6.43B
Retained Earnings % of Revenue i56.4%98.7%
Property, Plant & Equipment i55.80M0

Cash Flow Statement Comparison

MetricTRU (2024)CME (2025)
Operating Cash Flow i825.10M4.54B
Operating Cash Flow % of Revenue i19.7%69.6%
Capital Expenditures iN/A-83.50M
Free Cash Flow i516.70M4.19B
FCF Margin i12.4%64.3%
Debt Repayment i-1.99B-750.00M
Common Stock Repurchase iN/A-266.10M

Short Interest & Institutional Ownership Analysis

MetricTRUCME
Shares Short i5.61M4.70M
Short Ratio i2.852.28
Short % of Float i3.20%1.44%
Shares Outstanding i194.90M362.80M
Float Shares i194.47M357.72M
% Held by Insiders i0.34%0.48%
% Held by Institutions i103.01%91.89%
% Held by Public i-3.35%7.63%

Dividend Analysis & Yield Comparison: TransUnion vs CME Group Inc.

MetricTRUCME
Last 12-Month Dividend i$0.48$12.45
Last 12-Month Dividend Yield i0.61%4.11%
3-Year Avg Annual Dividend i$0.47$10.83
3-Year Avg Dividend Yield i0.14%0.92%
3-Year Total Dividends i$1.40$32.50
Ex-Dividend DateFeb 26, 2026Mar 10, 2026